Both in Pharmaceuticals
Spruce Biosciences vs Minerva Neurosciences
Over the past year SPRB returned −59.1% and NERV returned −38.5%; their daily moves had a correlation of 0.16.
SPRB −59.1% NERV −38.5%Growth of $1, one year, split-adjusted
| Metric | SPRB | NERV |
|---|---|---|
| Price | $42.81 | $2.35 |
| Market cap | $123.0M | $112.2M |
| Today | −3.91% | +0.21% |
| 1 month | −5.7% | −29.2% |
| 6 months | −27.9% | −62.4% |
| Year to date | −50.9% | −41.5% |
| 1 year | −61.1% | −44.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $89.2M | $75.3M |
| Dividend yield | — | — |
| Volatility (60d) | 64.5% | 78.0% |
| Short % of float | 22.4% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).